News from cormedix inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 14, 2014, 16:45 ET

FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jul 24, 2014, 12:30 ET

CorMedix, Inc. Granted Extension of NYSE-MKT Listing

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jun 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol for FDA

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

May 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Notified of NYSE MKT Listing Deficiency

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

May 13, 2014, 17:26 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Announce First Quarter 2014 Results on May 15, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic...

Apr 07, 2014, 08:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Welcomes Additional Board Members

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 27, 2014, 18:39 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Report 2013 Year End Results on March 31, 2014, and Host Conference Call at 9 am on April 1, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for...

Mar 10, 2014, 16:05 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Announces Close of Registered Direct Offering

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 04, 2014, 21:50 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Announces Registered Direct Offering

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jan 13, 2014, 08:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Expands Neutrolin® Sales with Middle East Distribution Agreements

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Jan 10, 2014, 08:32 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Awarded European Patent for Neutrolin

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Jan 08, 2014, 09:16 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Raise $2,000,000 in Follow On Offering

- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 23, 2013, 09:51 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Receives Minutes from Neutrolin Pre-IND Meeting with FDA

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 12, 2013, 11:14 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Announces First Sales of Neutrolin® in the European Union

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Nov 15, 2013, 11:43 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix to Report Third Quarter Financial Results on November 19, 2013

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Oct 23, 2013, 09:00 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Oct 18, 2013, 10:09 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Raise $3,000,000 in Concurrent Offerings

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Sep 05, 2013, 07:00 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

Aug 14, 2013, 18:48 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Reports Second Quarter 2013 Results

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

Jul 15, 2013, 15:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Granted Extension of NYSE MKT Listing

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...